NMPA Approval

Mixed Protamine Zinc Insulin Lispro Injection(50R)

Approval Number

国药准字S20240019

Company复星万邦（江苏）医药集团有限公司

Registration Date

May 21, 2024

Drug Information

Generic Name

精蛋白锌赖脯胰岛素混合注射液(50R)

Dosage Form

注射剂

Strength

3ml:300单位（笔芯）

Drug Type

生物制品

Registration Date

May 21, 2024

Company Information

Applicant Company

Company Name复星万邦（江苏）医药集团有限公司

Company Address

江苏省徐州市金山桥开发区综合区洞山南侧

Manufacturing Company

Company Name复星万邦（江苏）医药集团有限公司

Company Address

江苏省徐州市金山桥开发区综合区洞山南侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

精蛋白锌赖脯胰岛素混合注射液(50R) - NMPA 批准文号 | MedPath